Reteplase thrombolytic therapy on the lower extremity deep venous thrombosis
10.3969/j.issn.1671-8348.2015.02.021
- VernacularTitle:瑞替普酶治疗下肢深静脉血栓形成的临床观察
- Author:
Changlie ZHANG
;
Zhihong SONG
- Publication Type:Journal Article
- Keywords:
venous thrombosis;
lower extremity;
embolization,therapeutic;
reteplase;
recombinant streptokinase
- From:
Chongqing Medicine
2015;(2):207-208,211
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the treatment of the lower extremity deep venous thrombosis .Methods Sixty patients with lower extremity deep venous thrombosis were analyzed retrospectively .Thirty two patients underwent reteplase thrombosis ,and 28 patients underwent recombinant streptokinase thrombosis ;the effects of each group were compared;and the various complications and adverse events were observed .Results Patients in two groups were all effectively treated ,and the effective rate of reteplase group was higher than recombinant streptokinase group (P<0 .05) .The adverse rate of reteplase group was lower than recombi‐nant streptokinase group ,but there was no significant difference between two groups (P>0 .05) .During the follow‐up ,there was no reoccurrence in all 60 patients .Conclusion Reteplase thrombolytic therapy for the lower extremity deep venous thrombosis is safe and effective .
